by Raynovich Rod | May 20, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Rally Developing-Green Screen Alert If you are underweight large cap biotech add FBT ($76.38) up 2%. Most of our large cap picks are up today: ABBV ALXN, BIIB,GILD,REGN. Reverse pattern from tuesday’s downdraft. ————– One of the...
by Raynovich Rod | May 20, 2014 | 2024 Rayno Biopharmaceuticals Portfolio
Rayno Life Science Focus Stocks: ARIA, IMGN, PCYC Ariad (ARIA) Abstracts Several data presentations will be made for Iclusig (Ponatinib) for leukemias and AP26113 its investigational oral inhibitor of anaplastic lymphoma kinase (ALK). A breakfast meeting featuring...
by Raynovich Rod | May 15, 2014 | Biopharmaceuticals
Volatility Up as ASCO Approaches The ASCO Annual Meeting is not till the end of the month but news regarding abstract titles and clinical data that will be presented at ASCO moved stocks today. Many immuno-oncology stocks have been hard hit in the 2014 sell-off as...
by Raynovich Rod | May 1, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update August 5, 2014 Large Cap Biopharmaceutical Stocks Includes Q1 Earnings Reports (except REGN due 5/8) Rayno Focus Picks: ALXN, AMGN, BIIB, FBT, GILD, REGN, RHHBY Large cap stocks are core holdings especially now that sector momentum is easing. ABBV dropped...
by Raynovich Rod | Apr 17, 2014 | Biopharmaceuticals
Large Caps Are Recovering But Follow Q1 Earnings Closely Fidelity Select Biotech FBIOX( $176 ) must hold $172 for new buys. Healthcare sector XLV ($56.94) lagging industrials and energy. April 15 Low Must Hold IBB ($207.70) Our top picks that are off 5 day bottom and...
by Raynovich Rod | Apr 11, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Top Ten Reasons For Biotech Correction NASDAQ at 4022,IBB at 221 A Sentiment Driven Market We have been writing about the bull market in biotech stocks since its inception in March 2009 when quality companies were advancing their pipelines and new products in...
by Raynovich Rod | Apr 8, 2014 | 2024 Rayno Biopharmaceuticals Portfolio
NASDAQ Up 0.37% to 4133 Green screen alert with large cap biotechs. Time to cover hedges. Alexion (ALXN) up 2.23% Biogen (BIIB) Up 2.4% Celgene (CELG) up 3.61% Clovis Oncology (CLVS) up 2.85% Gilead (GILD) up 1.35% IBB up 1.96% Regeneron (REGN) up 3.99% Key Trends To...
by Raynovich Rod | Apr 1, 2014 | 2024 Rayno Biopharmaceuticals Portfolio
Rayno Biopharmaceutical Portfolio 3/31/14 Most of our biotech picks did well in a tough quarter that went through a severe correction in early February and again in late March. Many small and mid-cap momentum stocks were crushed but indices (FBT,IBB) overall held the...
by Raynovich Rod | Mar 18, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, 2024 Rayno Tools and Diagnostics Portfolio
Update 3/19/14 Trading is mixed near flat line. Cramer to pump Seattle Genetics (SGEN ($53.51 flat) today; on our focus list since’09 at $9.50. Exact Sciences (EXAS) up ~3% on data release for Cologuard compared to FIT. Sensitivity of 92% with colorectal cancer...
by Raynovich Rod | Feb 27, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Clinical Diagnostics and Tools
Rayno Life Science Movers -Diagnostics Review Next Week Despite some choppiness in biotech trading this week many of our stocks did well. I won’t go into some of the unusual volatility in other small and mid-caps lately but that is part of the reason for my...